This invention relates to a crystal form of the compound represented by formula I, and the preparation thereof including the preparation of an intermediate, a pharmaceutical composition thereof and the use thereof in the disease treatment or preparation of pharmaceutical formulation for the disease treatment.本發明涉及結構式I所示化合物的晶型、其製備方法包括中間體的製備、其藥物組合物,以及在治療疾病或製備治療疾病藥物製劑中的用途。